Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione

被引:34
作者
Onozaki, A [1 ]
Midorikawa, S [1 ]
Sanada, H [1 ]
Hayashi, Y [1 ]
Baba, T [1 ]
Katoh, T [1 ]
Watanabe, T [1 ]
机构
[1] Fukushima Med Univ, Sch Med, Dept Internal Med 3, Fukushima, Japan
关键词
protein kinase C; PPAR-gamma; pioglitazone;
D O I
10.1016/j.bbrc.2004.02.175
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic nephropathy is a common complication in diabetes mellitus (DM). Thiazolidinedione (TZD) is thought to ameliorate diabetic nephropathy, however, the mechanism has not been elucidated. We hypothesized that VEGF participates in the pathogenesis of diabetic nephropathy and that TZD may be beneficial for the treatment of diabetic nephropathy through its effect on VEGF. Increased VEGF expression was demonstrated in the glomeruli of DM rats and rat mesangial cells (RMC) incubated with high medium glucose. It was also demonstrated that VEGF promoted mesangial cell proliferation, which was inhibited by TZD. It was shown that a rapid fall and rise of ambient glucose concentration induces more VEGF production and cell proliferation in RMC than in cells with continuously high glucose medium, which was also inhibited by TZD. Prostaglandin J2 and protein C kinase inhibitors significantly inhibited [H-3]thymidine incorporation in RMC incubated with VEGF, which was inhibited by TZD. These findings indicate that a rapid change of glucose concentration promotes RMC proliferation by the increased Production of VEGF. TZD has an inhibitory action through, at least in part, PPAR-gamma. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 30 条
  • [1] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [2] Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
    Cooper, ME
    Vranes, D
    Youssef, S
    Stacker, SA
    Cox, AJ
    Rizkalla, B
    Casley, DJ
    Bach, LA
    Kelly, DJ
    Gilbert, RE
    [J]. DIABETES, 1999, 48 (11) : 2229 - 2239
  • [3] De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
  • [4] EFFECT OF IMPROVED METABOLIC CONTROL ON LOSS OF KIDNEY-FUNCTION IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS - AN UPDATE OF THE STENO STUDIES
    FELDTRASMUSSEN, B
    MATHIESEN, ER
    JENSEN, T
    LAURITZEN, T
    DECKERT, T
    [J]. DIABETOLOGIA, 1991, 34 (03) : 164 - 170
  • [5] CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS
    FUJIWARA, T
    YOSHIOKA, S
    YOSHIOKA, T
    USHIYAMA, I
    HORIKOSHI, H
    [J]. DIABETES, 1988, 37 (11) : 1549 - 1558
  • [6] Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy
    Hovind, P
    Tarnow, L
    Oestergaard, PB
    Parving, HH
    [J]. KIDNEY INTERNATIONAL, 2000, 57 : S56 - S61
  • [7] Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy
    Imano, E
    Kanda, T
    Nakatani, Y
    Nishida, T
    Arai, K
    Motomura, M
    Kajimoto, Y
    Yamasaki, Y
    Hori, M
    [J]. DIABETES CARE, 1998, 21 (12) : 2135 - 2139
  • [8] Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats
    Isshiki, K
    Haneda, M
    Koya, D
    Maeda, S
    Sugimoto, T
    Kikkawa, R
    [J]. DIABETES, 2000, 49 (06) : 1022 - 1032
  • [9] BINDING-SITES FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR ARE LOCALIZED ON ENDOTHELIAL-CELLS IN ADULT-RAT TISSUES
    JAKEMAN, LB
    WINER, J
    BENNETT, GL
    ALTAR, CA
    FERRARA, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) : 244 - 253
  • [10] VASCULAR-PERMEABILITY FACTOR, AN ENDOTHELIAL-CELL MITOGEN RELATED TO PDGF
    KECK, PJ
    HAUSER, SD
    KRIVI, G
    SANZO, K
    WARREN, T
    FEDER, J
    CONNOLLY, DT
    [J]. SCIENCE, 1989, 246 (4935) : 1309 - 1312